C. Byrne et al., SURVIVAL ADVANTAGE DIFFERENCES BY AGE - EVALUATION OF THE EXTENDED FOLLOW-UP OF THE BREAST-CANCER DETECTION DEMONSTRATION PROJECT, Cancer, 74(1), 1994, pp. 301-310
Background. This study considers breast cancer survival patterns by ag
e group among women diagnosed in the Breast Cancer Detection Demonstra
tion Project (BCDDP) to provide insight into the nature of breast canc
er and suggest a possible explanation as to why the results of the ran
domized clinical trials differ for women younger than 50 and those 50
or older. Based on the findings of several randomized clinical trials,
there is a general consensus that breast cancer screening provides a
significant benefit for women aged 50-69. From these trials, there is
little evidence of a short term benefit and uncertainty regarding any
long term benefit of mammographic screening for women aged 40-49. Meth
ods. The BCDDP was not a randomized trial, but a nationwide breast can
cer screening program conducted between 1973-1980, in which all partic
ipants received annual physical and mammographic examinations. Using t
he BCDDP data, this study calculated 14-year breast survival among 405
1 women diagnosed with cancer between 1973 and 1980 and followed throu
gh 1988 and 1989. Results. In all, 598 women died of breast cancer, re
sulting in an overall 14-year breast cancer survival of 83.4% (standar
d error = 0.007). Breast cancer survival varied by tumor type, lymph n
ode status, tumor size, and stage at diagnosis. For most of the cases,
however, both the distribution and breast cancer survival rates were
similar for women aged 40-49, 50-59, and 60-69 across all prognostic i
ndicators. Only breast cancer survival among women with invasive breas
t cancer who had a primary tumor 5 cm or larger or with positive lymph
nodes differed by age, with women aged 60-69 at diagnosis having poor
er survival. Analyses by modality of detection conducted in a subset o
f 2739 cases indicated that the 34.6% of the cases detected by mammogr
aphy alone had the highest overall breast cancer survival rates (90.9%
), while the 32.2% of the cases detectable by both physical examinatio
n and mammography had the lowest breast cancer survival (79.0%). Overa
ll, women diagnosed with breast cancer in the BCDDP had a survival adv
antage if diagnosed with either a smaller tumor or no positive lymph n
odes, or if their breast cancer was detected by mammography alone. For
women with large tumors (greater than or equal to 5 cm), the survival
was 80.8% for ages 40-49, 72.1% for ages 50-59, and 61.7% for ages 60
-69. Discussion. Due to the higher breast cancer survival rates among
women aged 40-49 with poorer prognostic characteristics, the breast ca
ncer survival advantage for having a smaller tumor, no positive lymph
nodes, or breast cancer detected by mammography alone was lower for wo
men aged 40-49 than women aged 50 or older at diagnosis. These differe
nces in survival advantage may help to account for the differences in
mortality by age in the randomized clinical trials.